Delivery Order SPE2DR25D3201-SPE2DR26FT5XT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,692.54 to AmerisourceBergen Drug Corp for Cortifoam 10% Aerosol 15GM, a pharmaceutical product for military medical supply needs. The award was issued on January 15, 2026, with an ultimate completion date of January 16, 2026, and utilized firm fixed-price pricing with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Cortifoam 10% Aerosol 15GM pharmaceutical product. This non-set-aside, competitively awarded delivery order carries a ceiling value of $6,638.37 under a firm fixed price contract structure, with an ultimate completion date of July 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,653.36 by the Defense Logistics Agency on October 28, 2025, for the supply of Cortifoam 10% Aerosol 15GM. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,259.20, is for the delivery of CORTIFOAM 10% AEROSOL 15GM medical supplies. The contract has a performance period ending on June 11, 2024 and is a firm-fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at...
- The Defense Logistics Agency awarded a $262,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for CORTIFOAM 10% aerosol. As part of its pharmaceutical supply chain management responsibilities, DLA issued this order under an existing Prime Vendor contract vehicle. Amerisourcebergen will deliver 15 grams of the topical medication to a customer located in Conshohocken, Pennsylvania by mid-August 2023. No subcontractors or set aside designations were identified. This order...
- This federal contract award, valued at $1,136.83, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a medical product, and has a completion date of May 5, 2023. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $1,140.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORTIFOAM 10% AEROSOL 15GM, a medical product, and has a completion date of December 9, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CORTIFOAM 10% AEROS 1S medical supplies, with a firm fixed price of $1,120.92 and a completion date of June 30, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with...
- <p>The Defense Logistics Agency awarded a $3,224.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561504123 CORTIFOAM 10% AEROSOL 15GM. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 14-17, 2023. The Defense Logistics Agency supports Department of Defense procurement through contracts for pharmaceuticals and medical supplies. No subcontractors or set aside designations were indicated.</p>
- The Defense Logistics Agency awarded a delivery order valued at $1,700.78 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10 gram units. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and has an ultimate completion date of January 28, 2026. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999,999,999.00...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT5XTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,734.64 to AmerisourceBergen Drug Corp for Cortifoam 10% Aerosol 15GM, a pharmaceutical product. This contract was awarded on January 28, 2026, with an ultimate completion date of January 29, 2026, and was executed without a set-aside designation through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. Cencora, Inc., operating under the AmerisourceBergen brand, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent company's comprehensive IDC with DLA enables delivery of a broad spectrum of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. AmerisourceBergen's consistent performance on federal contracts demonstrates its capability to efficiently fulfill government requirements for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/27/26 |